Filing Details
- Accession Number:
- 0001415889-24-019147
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-03 14:42:03
- Reporting Period:
- 2024-07-01
- Accepted Time:
- 2024-07-03 14:42:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1768446 | Eliem Therapeutics Inc. | ELYM | Pharmaceutical Preparations (2834) | 832273741 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1868517 | Valerie Morisset | C/O Eliem Therapeutics, Inc. Wilmington DE 19808 | Evp, R&D And Cso | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-07-01 | 7,649 | $0.00 | 512,956 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-07-03 | 50,000 | $6.76 | 462,956 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-07-01 | 7,649 | $0.00 | 7,649 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,198 | 2031-02-25 | No | 4 | M | Direct |
Footnotes
- The shares subject to this option shall vest at a rate of 12/48ths of the total number of shares on the one-year anniversary of February 26, 2021 (the "February 2021 Vesting Commencement Date") and 1/48thof the total number of shares each monthly anniversary of the February 2021 Vesting Commencement Date thereafter (or if there is no corresponding day, on the last day of the month) for so long as the Reporting Person remains an officer, director, employee, consultant and/or advisor of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the February 2021Vesting Commencement Date.